VHCP Co-Investment Holdings III, LLC insider trades: Lycia Therapeutics (LYCA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where VHCP Co-Investment Holdings III, LLC reports to the SEC
and 3 more companies
Open-market buys and sales
48 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | LYCA | ↑ Buy | 8,305 | $26.95 | $224K | By Funds | Nov 4, 2026 (2d) |
| Oct 30, 2026 | LYCA | ↑ Buy | 25,004 | $25.78 | $645K | By Funds | Oct 30, 2026 (0d) |
| Oct 27, 2026 | LYCA | ↑ Buy | 2,045,440 | $18.41 | $37.7M | By Funds | Oct 27, 2026 (0d) |
| Apr 9, 2025 | KALV | ↑ Buy | 25,000 | $9.42 | $236K | By Funds | Apr 11, 2025 (2d) |
| Feb 14, 2025 | ORKA | ↑ Buy | 122,882 | $11.45 | $1.4M | By Funds | Feb 27, 2025 (13d) |
| Feb 13, 2025 | KALV | ↑ Buy | 161,700 | $9.27 | $1.5M | By Funds | Feb 14, 2025 (1d) |
| Feb 11, 2025 | KALV | ↑ Buy | 104,489 | $9.26 | $967K | By Funds | Feb 11, 2025 (0d) |
| Feb 3, 2025 | KALV | ↑ Buy | 70,023 | $8.88 | $622K | By Funds | Feb 3, 2025 (0d) |
| Feb 8, 2024 | KALV | ↑ Buy | 86,048 | $14.62 | $1.3M | By Funds | Feb 8, 2024 (0d) |
| Jan 30, 2024 | KALV | ↑ Buy | 88,099 | $14.47 | $1.3M | By Funds | Feb 1, 2024 (2d) |
| Jan 29, 2024 | KALV | ↑ Buy | 91,804 | $14.05 | $1.3M | By Funds | Jan 29, 2024 (0d) |
| Jan 24, 2024 | KALV | ↑ Buy | 99,129 | $12.53 | $1.2M | By Funds | Jan 24, 2024 (0d) |
| Jan 19, 2024 | KALV | ↑ Buy | 143,605 | $12.55 | $1.8M | By Funds | Jan 19, 2024 (0d) |
| Jan 16, 2024 | KALV | ↑ Buy | 26,246 | $12.72 | $334K | By Funds | Jan 16, 2024 (0d) |
| Jan 10, 2024 | KALV | ↑ Buy | 137,700 | $12.54 | $1.7M | By Funds | Jan 10, 2024 (0d) |
| Jan 4, 2024 | KALV | ↑ Buy | 59,369 | $12.14 | $721K | By Funds | Jan 5, 2024 (1d) |
| Dec 29, 2023 | KALV | ↑ Buy | 519,017 | $12.46 | $6.5M | By Funds | Dec 29, 2023 (0d) |
| Oct 26, 2022 | TCDA | ↓ Sell | 6,451,540 | $0.54 | $3.5M | By Funds | Oct 26, 2022 (0d) |
| Oct 19, 2022 | TCDA | ↑ Buy | 351,866 | $10.68 | $3.8M | By Funds | Oct 20, 2022 (1d) |
| Oct 17, 2022 | TCDA | ↑ Buy | 174,966 | $11.68 | $2.0M | By Funds | Oct 17, 2022 (0d) |
| Oct 11, 2022 | TCDA | ↑ Buy | 134,214 | $11.91 | $1.6M | By Funds | Oct 11, 2022 (0d) |
| Oct 4, 2022 | TCDA | ↑ Buy | 223,100 | $11.81 | $2.6M | By Funds | Oct 6, 2022 (2d) |
| Oct 3, 2022 | TCDA | ↑ Buy | 436,923 | $10.75 | $4.7M | By Funds | Oct 3, 2022 (0d) |
| Sep 28, 2022 | TCDA | ↑ Buy | 587,214 | $8.90 | $5.2M | By Funds | Sep 28, 2022 (0d) |
| Sep 7, 2022 | TCDA | ↑ Buy | 686,712 | $11.53 | $7.9M | By Funds | Sep 7, 2022 (0d) |
| Aug 30, 2022 | TCDA | ↑ Buy | 50,000 | $12.20 | $610K | By Funds | Sep 1, 2022 (2d) |
| Jul 29, 2022 | TCDA | ↑ Buy | 18,900 | $9.21 | $174K | By Funds | Aug 2, 2022 (4d) |
| Jul 25, 2022 | TCDA | ↑ Buy | 74,199 | $9.26 | $687K | By Funds | Jul 25, 2022 (0d) |
| Jul 20, 2022 | TCDA | ↑ Buy | 150,000 | $9.18 | $1.4M | By Funds | Jul 20, 2022 (0d) |
| Jul 14, 2022 | TCDA | ↑ Buy | 94,573 | $9.88 | $935K | By Funds | Jul 14, 2022 (0d) |
| Jul 12, 2022 | VTGN | ↓ Sell | 60,000 | $0.89 | $53K | By Funds | Jul 14, 2022 (2d) |
| Jul 5, 2022 | TCDA | ↑ Buy | 88,200 | $9.61 | $847K | By Funds | Jul 6, 2022 (1d) |
| Jun 30, 2022 | TCDA | ↑ Buy | 62,870 | $9.76 | $614K | By Funds | Jun 30, 2022 (0d) |
| Jun 24, 2022 | TCDA | ↑ Buy | 492,020 | $10.37 | $5.1M | By Funds | Jun 24, 2022 (0d) |
| Jun 16, 2022 | TCDA | ↑ Buy | 5,951 | $9.69 | $58K | By funds | Jun 21, 2022 (5d) |
| Jun 14, 2022 | TCDA | ↑ Buy | 118,054 | $8.57 | $1.0M | By Funds | Jun 14, 2022 (0d) |
| Jun 9, 2022 | TCDA | ↑ Buy | 588,024 | $9.65 | $5.7M | By Funds | Jun 9, 2022 (0d) |
| Jun 6, 2022 | TCDA | ↑ Buy | 190,871 | $9.16 | $1.7M | By Funds | Jun 6, 2022 (0d) |
| Aug 18, 2020 | UMRX | ↑ Buy | 451,000 | $2.52 | $1.1M | By funds | Aug 18, 2020 (0d) |
| Jun 15, 2020 | ALT | ↑ Buy | 1,500,000 | $7.54 | $11.3M | By Funds | Jun 15, 2020 (0d) |
| May 28, 2020 | ALT | ↑ Buy | 1,303,636 | $8.74 | $11.4M | By Funds | May 28, 2020 (0d) |
| Dec 13, 2019 | CNST | ↑ Buy | 400,000 | $34.50 | $13.8M | By Funds | Dec 16, 2019 (3d) |
| Oct 28, 2019 | BLPH | ↓ Sell | 1,093,847 | $0.48 | $525K | By funds | Oct 28, 2019 (0d) |
| Mar 18, 2019 | KALV | ↓ Sell | 500,000 | $28.75 | $14.4M | By Funds | Mar 20, 2019 (2d) |
| Jan 23, 2019 | BLPH | ↑ Buy | 142,857 | $0.70 | $100K | By funds | Mar 14, 2019 (50d) |
| Sep 17, 2018 | BLPH | ↑ Buy | 210,000 | $1.20 | $252K | By funds | Sep 17, 2018 (0d) |
| Sep 12, 2018 | BLPH | ↑ Buy | 475,000 | $1.18 | $558K | By funds | Sep 12, 2018 (0d) |
| Sep 7, 2018 | BLPH | ↑ Buy | 160,000 | $0.86 | $138K | By funds | Sep 7, 2018 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LYCA insiders
Open-market trades in the last 12 months
About VHCP Co-Investment Holdings III, LLC's insider trades
VHCP Co-Investment Holdings III, LLC is a 10% owner of Lycia Therapeutics (LYCA). Since Sep 7, 2018, it has reported 44 open-market purchases worth $144.8M and 4 sales worth $18.5M on SEC Form 4. In the last 12 months: 3 buys ($38.5M).
Its filings also include other transactions (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LYCA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.